Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy).
Garcia J, Forestier J, Dusserre E, Wozny AS, Geiguer F, Merle P, Tissot C, Ferraro-Peyret C, Jones FS, Edelstein DL, Cheynet V, Bardel C, Vilchez G, Xu Z, Bringuier PP, Barritault M, Brengle-Pesce K, Guillet M, Chauvenet M, Manship B, Brevet M, Rodriguez-Lafrasse C, Hervieu V, Couraud S, Walter T, Payen L.
Garcia J, et al. Among authors: payen l.
Oncotarget. 2018 Apr 20;9(30):21122-21131. doi: 10.18632/oncotarget.24950. eCollection 2018 Apr 20.
Oncotarget. 2018.
PMID: 29765524
Free PMC article.